BOLTON SECURITIES CORPORATION’s Amgen AMGN Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$3.16M	Buy	+10,127	New	+$2.99M	0.19%	145

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's AMGN Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Amgen (AMGN) in Q1 2025: 10,127 shares worth $3.16M. The stake represents 0.19% of the portfolio and ranks #145 among its holdings.

2,939 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

BOLTON SECURITIES CORPORATION held 10,127 shares of Amgen worth $3.16M as of Q1 2025.
Amgen was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Amgen made up 0.19% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #145 holding.
2,939 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.